ML364是一种泛素蛋白特异性肽酶(USP2)抑制剂，可用于乳腺癌的研究，摘自专利WO2016134026A1，化合物Figure10G。
| Cas No. | 1991986-30-1 |
| Canonical SMILES | O=C(NC1=NC(C2=CC=CC=C2)=CS1)C3=CC=C(C(F)(F)F)C=C3NS(=O)(C4=CC=C(C)C=C4)=O |
| 分子式 | C24H18F3N3O3S2 |
| 分子量 | 517.54 |
| 溶解度 | DMSO : ≥ 33 mg/mL (63.76 mM) |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request |
| 产品描述 | ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2), and can be used for the research of breast cancer, extracted from patent WO 2016134026 A1, compound Figure 10G. [1]. Methods and materials for assessing chemotherapy responsiveness and treating cancer. WO 2016134026 A1 |
